Phenol-soluble modulins: Novel virulence-associated peptides of staphylococci

Future Microbiology

Volumn 9, Issue 2, 2014, Pages 203-216

  Li, Shu ^a   Huang, Hui ^a   Rao, Xiancai ^a   Chen, Wei ^a   Wang, Zhengqing ^a   Hu, Xiaomei ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Agr QS system; Biofilm; Peptide; Phenol soluble modulin; Staphylococcus aureus; Staphylococcus epidermidis; Virulence

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; L SELECTIN; LIPOPROTEIN; PHENOL SOLUBLE MODULIN DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRULENCE FACTOR; PEPTIDE; PHENOL; PHENOL SOLUBLE MODULIN;

ADAPTIVE IMMUNITY; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; BACTERIAL VIRULENCE; BIOFILM; CELL INTERACTION; CELL MATURATION; CELL MIGRATION; CELL SURFACE; CHEMICAL STRUCTURE; CIRCULAR DICHROISM; CLASSIFICATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ELECTROSPRAY MASS SPECTROMETRY; ERYTHROCYTE; ESCHERICHIA COLI; HEMOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INNATE IMMUNITY; LEGIONELLA; LIPOPROTEIN BLOOD LEVEL; MICROCOCCUS LUTEUS; MOLECULAR WEIGHT; MONOCYTE; NEUTROPHIL; NONHUMAN; OPEN READING FRAME; PENICILLIN RESISTANCE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; QUORUM SENSING; REVIEW; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS COHNII; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS INFECTION; STAPHYLOCOCCUS LUGDUNENSIS; STAPHYLOCOCCUS PSEUDINTERMEDIUS; STAPHYLOCOCCUS SAPROPHYTICUS; STAPHYLOCOCCUS SCIURI; STAPHYLOCOCCUS SIMULANS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PYOGENES; ANTIBACTERIAL ACTIVITY; GENE EXPRESSION REGULATION; INFLAMMATION; PROTEIN LOCALIZATION;

BACTERIAL PROTEINS; BIOFILMS; CYTOKINES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ERYTHROCYTES; HEMOLYSIS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; NEUTROPHILS; QUORUM SENSING; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; VIRULENCE FACTORS;

EID: 84896812498     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.13.153     Document Type: Review

References (87)

1. Diekema DJ, Pfaller MA, Schmitz FJ et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis. 32, S114-S132 (2001). (Pubitemid 32424266)
2. Franklin D, Lowy MD. Staphylococcus aureus infections. N. Engl. J. Med. 339, 520-532 (1998).
3. DeLeo FR, Chambers HF. Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J. Clin. Invest. 119, 2464-2474 (2009).
4. Mediavilla JR, Chen L, Mathema B, Kreiswirth BN. Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA). Curr. Opin. Microbiol. 15, 588-595 (2012).
5. McCann MT, Gilmore BF, Gorman SP. Staphylococcus epidermidis device-related infections: pathogenesis and clinical management. J. Pharm. Pharmacol. 60, 1551-1571 (2008).
6. Laverty G, Gorman SP, Gilmore BF. Biomolecular mechanisms of staphylococcal biofilm formation. Future Microbiol. 8, 509-524 (2013).
7. Klevens RM, Morrison MA, Nadle J et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298, 1763-1771 (2007). (Pubitemid 47598444)
8. Bancroft EA. Antimicrobial resistance: it's not just for hospitals. JAMA 298, 1803-1804 (2007). (Pubitemid 47598451)
9. Xiao YH, Shen P, Wei ZQ et al. Mohnarin report of 2010: surveillance of bacterial resistance in China. Chinese J. Nosocomiol. 21, 4896-4902 (2011).
10. Mehlin C, Headley CM, Klebanoff SJ. An inflammatory polypeptide complex from Staphylococcus epidermidis: isolation and characterization. J. Exp. Med. 189, 907-918 (1999).
11. Queck SY, Khan BA, Wang R et al. Mobile genetic element-encoded cytolysin connects virulence to methicillin resistance in MRSA. PLoS Pathog. 5, e1000533 (2009).
12. Chatterjee SS, Chen L, Joo HS, Cheung GY, Kreiswirth BN, Otto M. Distribution and regulation of the mobile genetic element-encoded phenol-soluble modulin PSM-mec in methicillin-resistant Staphylococcus aureus. PLoS ONE 6, e28781 (2011).
13. Vuong C, Durr M. Carmody AB, Peschel A, Klebanoff SJ, Otto M. Regulated expression of pathogen-associated molecular pattern molecules in Staphylococcus epidermidis: quorum sensing determines pro-inflammatory capacity and production of phenol-soluble modulins. Cell Microbiol. 6, 753-759 (2004). •• Indicates that phenol-soluble modulin (PSM) synthesis is regulated strictly by the agr quorum-sensing system. (Pubitemid 39077381)
14. Wang R, Braughton KR, Kretschmer D et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat. Med. 13, 1510-1514 (2007). •• Indicates the remarkable ability of PSM peptides to recruit, activate and subsequently lyse neutrophils, and demonstrates the contribution of PSMs to the enhanced virulence of community-acquired methicillin-resistant Staphylococcus aureus. (Pubitemid 350224240)
15. Yao Y, Sturdevant DE, Otto M. Genomewide analysis of gene expression in Staphylococcus epidermidis biofilms: insights into the pathophysiology of S. epidermidis biofilms and the role of phenol-soluble modulins in formation of biofilms. J. Infect. Dis. 191, 289-298 (2005). (Pubitemid 40096388)
16. Periasamy S, Chatterjee SS, Cheung GY, Otto M. Phenol-soluble modulins in staphylococci: what are they originally for? Commun. Integr. Biol. 5, 275-277 (2012).
17. Gonzalez DJ, Okumura CY, Hollands A et al. Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometry. J. Biol. Chem. 287, 13889-13898 (2012).
18. Kretschmer D, Nikola N, Dürr M, Otto M, Peschel A. The Virulence regulator agr controls the staphylococcal capacity to activate human neutrophils via the formyl peptide receptor 2. J. Innate Immun. 4, 201-212 (2012).
19. Wang R, Khan BA, Cheung GY et al. Staphylococcus epidermidis surfactant peptides promote biofilm maturation and dissemination of biofilm-associated infection in mice. J. Clin. Invest. 12, 238-248 (2011). •• Demonstrates that PSMb peptides promote Staphylococcus epidermidis biofilm structuring and detachment in vitro and dissemination in vivo in a mouse model, highlighting the significance of PSMs for biofilm detachment and the systemic spread of biofilm-associated infections.
20. Frenette M, Beaudet R, Bisaillon JG, Sylvestre M, Portelance V. Chemical and biological characterization of a gonococcal growth inhibitor produced by Staphylococcus haemolyticus isolated from urogenital flora. Infect. Immun. 46, 340-345 (1984). (Pubitemid 15204601)
21. Otto M, O'Mahoney DS, Guina T, Klebanoff SJ. Activity of Staphylococcus epidermidis phenol-soluble modulin peptides expressed in Staphylococcus carnosus. J. Infect. Dis. 190, 748-755 (2004). (Pubitemid 39050005)
22. Wade JD, Lin F, Hossain MA, Dawson RM. Chemical synthesis and biological evaluation of an antimicrobial peptide gonococcal growth inhibitor. Amino Acids 43, 2279-2283 (2012).
23. Donvito B, Etienne J, Denoroy L, Greenland T, Benito Y, Vandenesch F. Synergistic hemolytic activity of Staphylococcus lugdunensis is mediated by three peptides encoded by a non-agr genetic locus. Infect. Immun. 65, 95-100 (1997). (Pubitemid 27008908)
24. Cheung GYC, Rigby K, Wang R et al. Staphylococcus epidermidis strategies to avoid killing by human neutrophils. PLoS Pathog. 6, e1001133 (2010).
25. Chen L, Mediavilla JR, Oliveira DC, Willey BM, de Lencastre H, Kreiswirth BN. Multiplex real-time PCR for rapid staphylococcal cassette chromosome mec typing. J. Clin. Microbiol. 47, 3692-3706 (2009).
26. Monecke S, Engelmann I, Archambault M et al. Distribution of SCCmec-associated phenol-soluble modulin in staphylococci. Mol. Cell. Probes 26, 99-103 (2012).
27. Otto M. Staphylococcus aureus toxin gene hitchhikes on a transferable antibiotic resistance element. Virulence 1, 49-51 (2010).
28. Cheung GY, Kretschmer D, Queck SY et al. Insight into structure-function relationship in phenol-soluble modulins using an alanine screen of the phenol-soluble modulin (PSM) a3 peptide. FASEB J. doi:10.1096/fj.13-232041 (2013) (Epub ahead of print).
29. Kaito C, Saito Y, Nagano G et al. Transcription and translation products of the cytolysin gene psm-mec on the mobile genetic element SCCmec regulate Staphylococcus aureus virulence. PLoS Pathog. 7, e1001267 (2011).
30. Novick RP. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol. Microbiol. 48, 1429-1449 (2003). (Pubitemid 36751052)
31. Arvidson S, Tegmark K. Regulation of virulence determinants in Staphylococcus aureus. Int. J. Med. Microbiol. 291, 159-170 (2001).
32. Laverty G, Gorman SP, Gilmore BF. Biomolecular mechanisms of staphylococcal biofilm formation. Future Microbiol. 8, 509-524 (2013).
33. Queck SY, Jameson-Lee M, Villaruz AE et al. RNAIII-independent target gene control by the agr quorum sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus. Mol. Cell 32, 150-158 (2008). •• Reveals that the regulatory function of the agr system on PSM production is AgrA dependent and RNAIII independent.
34. Zhao L, Xue T, Shang F, Sun H, Sun B. Staphylococcus aureus AI-2 quorum sensing associates with the KdpDE two-component system to regulate capsular polysaccharide synthesis and virulence. Infect. Immun. 78, 3506-3515 (2010).
35. Li M, Villaruz AE, Vadyvaloo V, Sturdevant DE, Otto M. AI-2-dependent gene regulation in Staphylococcus epidermidis. BMC Microbiol. 8, 4 (2008).
36. Zielinska AK, Beenken KE, Joo HS et al. Defining the strain-dependent impact of the staphylococcal accessory regulator (sarA) on the alpha-toxin phenotype of Staphylococcus aureus. J. Bacteriol. 193, 2948-2958 (2011).
37. Cheung AL, Projan SJ. Cloning and sequencing of sarA of Staphylococcus aureus, a gene required for the expression of agr. J. Bacteriol. 176, 4168-4172 (1994). (Pubitemid 24191304)
38. Chien Y, Manna AC, Cheung AL. SarA level is a determinant of agr activation in Staphylococcus aureus. Mol. Microbiol. 30, 991-1001 (1998). (Pubitemid 28550123)
39. Kobayashi SD, Malachowa N, Whitney AR et al. Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J. Infect. Dis. 204, 937-941 (2011).
40. Henderson B, Poole S, Wilson M. Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol. Rev. 60, 316-341 (1996). (Pubitemid 26170909)
41. Liles WC, Thomsen AR, O'Mahony DS, Klebanoff SJ. Stimulation of human neutrophils and monocytes by staphylococcal phenol-soluble modulin. J. Leukoc. Biol. 70, 96-102 (2001). (Pubitemid 32613668)
42. Rautenberg M, Joo HS, Otto M, Peschel A. Neutrophil responses to staphylococcal pathogens and commensals via the formyl peptide receptor 2 relates to phenol-soluble modulin release and virulence. FASEB J. 25, 1254-1263 (2011).
43. Kretschmer D, Gleske AK, Rautenberg M et al. Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus. Cell Host Microbe 7, 463-473 (2010).
44. Clarke SR. Phenol-soluble modulins of Staphylococcus aureus lure neutrophils into battle. Cell Host Microbe 7, 423-424 (2010).
45. Fu H, Karlsson J, Bylund J, Movitz C, Karlsson A, Dahlgren C. Ligand recognition and activation of formyl peptide receptors in neutrophils. J. Leukoc. Biol. 79, 247-256 (2006). (Pubitemid 44831156)
46. Schiffmann E, Corcoran BA, Wahl SM. N-formylmethionyl peptides as chemoattractants for leucocytes. Proc. Natl Acad. Sci. USA 72, 1059-1106 (1975).
47. DeLeo FR, Diep BA, Otto M. Host defense and pathogenesis in Staphylococcus aureus infections. Infect. Dis. Clin. North Am. 23, 17-34 (2009).
48. Mayer-Scholl A, Averhoff P, Zychlinsky A. How do neutrophils and pathogens interact? Curr. Opin. Microbiol. 7, 62-66 (2004). (Pubitemid 38223956)
49. Rigby KM, DeLeo FR. Neutrophils in innate host defense against Staphylococcus aureus infections. Semin. Immunopathol. 34, 237-259 (2012).
50. Urban CF, Lourido S, Zychlinsky A. How do microbes evade neutrophil killing? Cell. Microbiol. 8, 1687-1696 (2006). (Pubitemid 44530662)
51. Giese B, Glowinski F, Paprotka K et al. Expression of d-toxin by Staphylococcus aureus mediates escape from phago-endosomes of human epithelial and endothelial cells in the presence of b-toxin. Cell. Microbiol. 13, 316-329 (2011).
52. Voyich JM, Braughton KR, Sturdevant DE et al. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J. Immunol. 175, 3907-3919 (2005). (Pubitemid 41292051)
53. Kobayashi SD, Braughton KR, Palazzolo- Ballance AM et al. Rapid neutrophil destruction following phagocytosis of Staphylococcus aureus. J. Innate Immun. 2, 560-575 (2010).
54. Otto M. Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus. Annu. Rev. Microbiol. 64, 143-162 (2010).
55. Surewaard BG, Nijland R, Spaan AN et al. Inactivation of staphylococcal phenol soluble modulins by serum lipoprotein particles. PLoS Pathog. 8, e1002606 (2012). •• Indicates that PSMs can be functionally neutralized by the abundantly present serum lipoproteins, suggesting that PSMs can only exert their function as intracellular toxins in intracellular or other lipoprotein-free niches within a body.
56. Surewaard BG, de Haas CJ, Vervoort F et al. Staphylococcal alpha-phenol soluble modulins contribute to neutrophil lysis after phagocytosis. Cell. Microbiol. 15, 1427-1437 (2013). • Demonstrates that the cytolytic toxicities of PSMa peptides are elicited inside neutrophils after phagocytosis.
57. Geiger T, Francois P, Liebeke M et al. The stringent response of Staphylococcus aureus and its impact on survival after phagocytosis through the induction of intracellular PSMs expression. PLoS Pathog. 8, e1003016 (2012).
58. Schreiner J, Kretschmer D, Klenk J et al. Staphylococcus aureus phenol-soluble modulin peptides modulate dendritic cell functions and increase in vitro priming of regulatory T cells. J. Immunol. 190, 3417-3426 (2013).
59. Donlan RM. Biofilms: microbial life on surfaces. Emerg. Infect. Dis. 8, 881-890 (2002). (Pubitemid 35000803)
60. McDougald D, Rice SA, Barraud N, Steinberg PD, Kjelleberg S. Should we stay or should we go: mechanisms and ecological consequences for biofilm dispersal. Nat. Rev. Microbiol. 10, 39-50 (2011).
61. Otto M. Staphylococcal biofilms. Curr. Top. Microbiol. Immunol. 322, 207-228 (2008).
62. Periasamy S, Joo HS, Duong AC et al. How Staphylococcus aureus biofilms develop their characteristic structure. Proc. Natl Acad. Sci. USA 109, 1281-1286 (2012). •• Identifies PSM peptides (especially b-type PSMs) as being the key biofilm structuring factors in S. aureus.
63. Molloy S. Biofilms: biofilms take shape. Nat. Rev. Microbiol. 10, 162 (2012).
64. Otto M. Staphylococcal infections: mechanisms of biofilm maturation and detachment as critical determinants of pathogenicity. Annu. Rev. Med. 64, 175-188 (2013).
65. Vuong C, Gerke C, Somerville GA, Fischer ER, Otto M. Quorum-sensing control of biofilm factors in Staphylococcus epidermidis. J. Infect. Dis. 188, 706-718 (2003). (Pubitemid 37115184)
66. Kong KF, Vuong C, Otto M. Staphylococcus quorum sensing in biofilm formation and infection. Int. J. Med. Microbiol. 296, 133-139 (2006). (Pubitemid 43375996)
67. Schwartz K, Syed AK, Stephenson RE, Rickard AH, Boles BR. Functional amyloids composed of phenol soluble modulins stabilize Staphylococcus aureus biofilms. PLoS Pathog. 8, e1002744 (2012).
68. Maróti G, Kereszt A, Kondorosi E, Mergaert P. Natural roles of antimicrobial peptides in microbes, plants and animals. Res. Microbiol. 162, 363-374 (2011).
69. Guaní-Guerra E, Santos-Mendoza T, Lugo- Reyes SO, Terán LM. Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin. Immunol. 135, 1-11 (2010).
70. Cogen AL, Yamasaki K, Sanchez KM et al. Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin. J. Invest. Dermatol. 130, 192-200 (2010).
71. Cogen AL, Yamasaki K, Muto J et al. Staphylococcus epidermidis antimicrobial delta-toxin (phenol-soluble modulin-gamma) cooperates with host antimicrobial peptides to kill group A Streptococcus. PLoS ONE 5, e8557 (2010).
72. Marchand A, Verdon J, Lacombe C, Crapart S, Hechard Y, Berjeaud JM. Anti-Legionella activity of staphylococcal hemolytic peptides. Peptides 32, 845-851 (2011).
73. Joo HS, Cheung GY, Otto M. Antimicrobial activity of community-associated methicillin-resistant Staphylococcus aureus is caused by phenol-soluble modulin derivatives. J. Biol. Chem. 286, 8933-8940 (2011).
74. Cheung GY, Duong AC, Otto M. Direct and synergistic hemolysis caused by Staphylococcus phenol-soluble modulins: implications for diagnosis and pathogenesis. Microbes Infect. 14, 380-386 (2012).
75. Rasigade JP, Trouillet-Assant S, Ferry T et al. PSMs of hypervirulent Staphylococcus aureus act as intracellular toxins that kill infected osteoblasts. PLoS ONE 8, e63176 (2013).
76. Pokorny A, Birkbeck TH, Almeida PF. Mechanism and kinetics of delta-lysin interaction with phospholipids vesicles. Biochemistry 41, 11044-11056 (2002). (Pubitemid 35001219)
77. Kaito C, Saito Y, Ikuo M et al. Mobile genetic element SCCmec-encoded psm-mec RNA suppresses translation of agrA and attenuates MRSA virulence. PLoS Pathog. 9, e1003269 (2013).
78. Tsompanidou E, Sibbald MJ, Chlebowicz MA et al. Requirement of the agr locus for colony spreading of Staphylococcus aureus. J. Bacteriol. 193, 1267-1272 (2011).
79. Kaito C, Sekimizu K. Colony spreading in Staphylococcus aureus. J. Bacteriol. 189, 2553-2557 (2007). (Pubitemid 46411369)
80. Tsompanidou E, Denham EL, Becher D et al. Distinct roles of phenol-soluble modulins in spreading of Staphylococcus aureus on wet surfaces. Appl. Environ. Microbiol. 79, 886-895 (2013).
81. Chatterjee SS, Joo HS, Duong AC et al. Essential Staphylococcus aureus toxin export system. Nat. Med. 19, 364-367 (2013). •• Reveals the exocellular secretion mechanisms that are present in all PSM peptides, which represents a potential single target for the complete obstruction of PSM production.
82. Chatterjee SS, Otto M. How can Staphylococcus aureus phenol-soluble modulins be targeted to inhibit infection? Future Microbiol. 8, 693-696 (2013).
83. Tsompanidou E, Denham EL, van Dijl JM. Phenol-soluble modulins, hellhounds from the staphylococcal virulence-factor pandemonium. Trends Microbiol. 21, 313-315 (2013).
84. Adhikari RP, Ajao AO, Aman MJ et al. Lower antibody levels to Staphylococcus aureus exotoxins are associated with sepsis in hospitalized adults with invasive S. aureus infections. J. Infect. Dis. 206, 915-923 (2012).
85. Balaban N, Stoodley P, Fux CA, Wilson S, Costerton JW, Dell'Acqua G. Prevention of staphylococcal biofilm-associated infections by the quorum sensing inhibitor RIP. Clin. Orthop. Relat. Res. 437, 48-54 (2005). (Pubitemid 41099065)
86. Kiran MD, Adikesavan NV, Cirioni O et al. Discovery of a quorum-sensing inhibitor of drug-resistant staphylococcal infections by structure-based virtual screening. Mol. Pharmacol. 73, 1578-1586 (2008). (Pubitemid 351574847)
87. Malladi VL, Sobczak AJ, Meyer TM, Pei D, Wnuk SF. Inhibition of LuxS by S-ribosylhomocysteine analogues containing a [4-aza]ribose ring. Bioorg. Med. Chem. 19, 5507-5519 (2011).